文献速递医学教育与科研方法流行病学与生物统计

GRADE 指南 36:GRADE 处理不一致性方法的更新

GRADE guidance 36: updates to GRADE's approach to addressing inconsistency.
PubMed 文献 · J Clin Epidemiol · 2023-03-09

该指南由 GRADE 工作组通过多轮书面反馈与会议讨论迭代制定,澄清了不一致性评估与效应修饰因子可信度评估两个领域。指南明确不一致性指结果变异而非研究特征变异,并说明二分类结局需同时考虑相对与绝对效应、如何权衡宽窄问题、不一致性评级可因确定性评级目标而异及其与 I² 的关系,并以实例展示从亚组分析到效应修饰可信度评估再到亚组特异性效应估计与 GRADE 确定性评级的步骤。

要点

  • 不一致性指结果变异而非研究特征变异,二分类结局需同时考虑相对与绝对效应。
  • 不一致性评级可因确定性评级目标不同而不同,与 I² 的关系取决于观察结果的背景。
  • 指南以实例展示从亚组分析到效应修饰可信度评估再到亚组特异性效应估计与 GRADE 评级的步骤。

核心结论

  • 该更新指南解决了系统评价作者在考虑跨研究治疗效应估计不一致程度时经常面临的具体概念与实践问题。

研究设计与样本

  • 采用迭代过程,通过多轮书面反馈与 GRADE 工作组会议讨论咨询工作组成员。

主要发现

  • 指南澄清不一致性指结果变异而非研究特征变异。
  • 指南澄清二分类结局的不一致性评估需同时考虑相对效应与绝对效应。
  • 指南说明在系统评价与指南中如何决定采用较窄或较宽的问题。
  • 指南指出同一证据下不一致性评级可能因确定性评级目标不同而不同。
  • 指南说明 GRADE 不一致性评级与统计量 I² 的关系取决于观察结果的背景。

关键数值与推荐

  • 指南第二部分以实例展示使用工具评估效应修饰分析的可信度。
  • 指南说明从亚组分析到评估效应修饰可信度的逐步过程,若认为可信则进一步得出亚组特异性效应估计与 GRADE 确定性评级。

临床怎么用

  • 系统评价作者可依据该指南评估跨研究治疗效应估计的不一致性。
  • 系统评价作者可依据该指南评估效应修饰分析的可信度并得出亚组特异性效应估计与 GRADE 确定性评级。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To update previous Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidance by addressing inconsistencies and interpreting subgroup analyses. STUDY DESIGN AND SETTING: Using an iterative process, we consulted with members of the GRADE working group through multiple rounds of written feedback and discussions at GRADE working group meetings. RESULTS: The guidance complements previous guidance with clarification in two areas: (1) assessing inconsistency and (2) assessing the credibility of possible effect modifiers that might explain inconsistency. Specifically, the guidance clarifies that inconsistency refers to variability in results, not in study characteristics; that inconsistency assessment for binary outcomes requires consideration of both relative and absolute effects; how to decide between narrower and broader questions in systematic reviews and guidelines; that, with the same evidence, ratings of inconsistency may differ depending on the target of certainty rating; and how GRADE inconsistency ratings relate to a statistical measure of inconsistency I2 depending on the context in which one views results. The second part of the guidance illustrates, based on a worked example, the use of the instrument to assess the credibility of effect modification analyses. The guidance explains the stepwise process of moving from a subgroup analysis to assessing the credibility of effect modification and, if found credible, to subgroup-specific effect estimates and GRADE certainty ratings. CONCLUSION: This updated guidance addresses specific conceptual and practical issues that systematic review authors frequently face when considering the degree of inconsistency in estimates of treatment effects across studies.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Guyatt G, Zhao Y, Mayer M, et al. GRADE guidance 36: updates to GRADE's approach to addressing inconsistency. J Clin Epidemiol. 2023. PMID: 36898507. doi:10.1016/j.jclinepi.2023.03.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。